In medical settings, CDI most commonly stands for Clostridioides difficile infection, a bacterial gut infection that causes diarrhea and inflammation of the colon. It’s one of the most frequently discussed hospital-associated infections, with about 117 cases per 100,000 people reported at CDC surveillance sites in 2023. However, CDI can also refer to two other medical concepts: central diabetes insipidus (a hormonal disorder) and clinical documentation improvement (a hospital administrative process). Which meaning applies depends entirely on context.
Clostridioides Difficile Infection: The Most Common Use
When doctors, nurses, or lab reports use “CDI,” they’re almost always talking about an infection caused by a bacterium called Clostridioides difficile (often shortened to C. diff). This germ produces toxins that directly damage the lining of the large intestine, breaking down the connections between cells and triggering inflammation, fluid buildup, and tissue death. The result is watery diarrhea, abdominal cramping, fever, and in severe cases, a life-threatening condition called fulminant colitis.
C. diff is especially dangerous because it forms spores that can survive on surfaces for months. Standard alcohol-based hand sanitizers don’t kill these spores, which is why hospitals use specialized cleaning products and require healthcare workers to wear gowns and gloves when treating patients with CDI.
Who Gets CDI and Why
The single biggest risk factor for CDI is recent antibiotic use. Broad-spectrum antibiotics wipe out large portions of the normal gut bacteria that ordinarily keep C. diff in check. With that competition removed, C. diff can multiply rapidly and start producing its damaging toxins. This is why CDI so often develops during or shortly after a course of antibiotics, particularly in hospital or nursing home settings where the bacterium is common.
Other factors that raise your risk include advanced age, chronic medical conditions, and the use of acid-reducing stomach medications called proton pump inhibitors (PPIs). An FDA review found that 23 out of 28 studies showed a higher risk of C. diff infection in people taking PPIs compared to those who weren’t. CDI rates also increase with age, are higher in women than men, and are most common among Native Hawaiian/Pacific Islander and White populations.
How CDI Is Diagnosed
Diagnosis starts with symptoms, particularly new, unexplained watery diarrhea (usually three or more loose stools in 24 hours). From there, a stool sample is tested using one or more of four main laboratory methods.
- Molecular (PCR) tests are same-day tests that detect genetic material from toxin-producing C. diff. They’re highly sensitive and specific.
- Antigen tests are rapid (under one hour) but not specific enough to confirm CDI on their own, so they’re typically paired with a second test.
- Toxin tests look for the actual toxins C. diff produces. They’re inexpensive and fast but can miss cases because the toxin breaks down quickly at room temperature, sometimes becoming undetectable within two hours of stool collection.
- Stool cultures are the most sensitive option but take 48 to 96 hours to produce results and require specialized lab conditions.
Many hospitals use a two-step approach, running a quick screening test first and then confirming with a more specific one.
How CDI Is Treated
Treatment centers on specific antibiotics that target C. diff while sparing other gut bacteria as much as possible. Current guidelines from the Infectious Diseases Society of America recommend fidaxomicin as the preferred first-line option for an initial episode, though vancomycin (taken by mouth, not IV) remains an acceptable alternative. For the most severe, life-threatening cases, higher doses of vancomycin are used.
One of the trickiest aspects of CDI is recurrence. The infection comes back in roughly 1 in 5 patients after initial treatment, and each recurrence makes the next one more likely. This happens because the underlying problem, a disrupted gut microbiome, hasn’t been fully corrected. For people with multiple recurrences, fecal microbiota treatments that restore healthy gut bacteria have become an important option.
Central Diabetes Insipidus
Outside of infectious disease contexts, CDI can stand for central diabetes insipidus, a rare hormonal condition affecting roughly 1 in 25,000 people. Despite the name, it has nothing to do with blood sugar or the more familiar type 1 and type 2 diabetes. Instead, it involves a shortage of a hormone called vasopressin (also known as antidiuretic hormone), which tells the kidneys how much water to retain.
When vasopressin production drops, the kidneys can’t concentrate urine properly. People with CDI produce large volumes of very dilute urine, typically more than 3 liters per day, and in severe cases more than 10 liters. That kind of fluid loss creates intense, constant thirst and a need to urinate every one to two hours, including throughout the night.
The most common causes are brain tumors (particularly craniopharyngiomas), pituitary surgery, and inflammatory conditions that damage the part of the brain responsible for making vasopressin. About 13% of cases have no identifiable cause and are labeled idiopathic. A small number are genetic, caused by mutations in the vasopressin gene that are usually inherited from one parent.
Central diabetes insipidus is distinct from nephrogenic diabetes insipidus, where the brain produces enough vasopressin but the kidneys don’t respond to it properly. The treatment approaches differ significantly, which is why pinpointing whether the problem is “central” (brain) or “nephrogenic” (kidney) matters.
Clinical Documentation Improvement
In hospital administration and medical billing, CDI stands for clinical documentation improvement. These are programs designed to make sure that what doctors write in patient charts accurately reflects how sick a patient is, what conditions they have, and what care they need. This matters because hospital reimbursement, quality scores, and public reporting metrics all flow from the medical record. If a physician’s notes are vague or incomplete, the hospital may be underpaid for the care it delivered, or its quality metrics may not reflect reality. CDI specialists, often nurses or coders with clinical training, review charts and query physicians to fill in gaps.